Charles Schwab Investment Management Inc Cabaletta Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 118,327 shares of CABA stock, worth $504,073. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,327
Previous 93,525
26.52%
Holding current value
$504,073
Previous $1.6 Million
44.51%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CABA
# of Institutions
145Shares Held
50.1MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$23.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$20.3 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$16.5 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12.9 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$11.2 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $124M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...